Over-Expression of COX-2 Induces Human Ovarian Cancer Cells (CAOV-3) Viability, Migration and Proliferation in Association with PI3-k/Akt Activation

REFERENCES

• Lorusso D., Ferrandina G., Graggi S., Gadduci A., Pignata S., Tateo S., Bia-monte R., Manzione L., Di Vagno G., Ferrau F., Scambia G., Phase I II. multicenter randomized trial of amifostine as cytoprotect-ant in first-line chemotherapy in ovarian cancer patients. Ann Oncol 2003; 14: 1086–1093
   PubMed Web of Science ®Google Scholar
• Melichar B., Urbanek L., Krcmova L., Kalabova H., Svobodova I., Drag-ounova E., Vesely P., Hyspler R., Solichova D. Urinary neopterin in patients with ovarian cancer. Pteridines 2006; 17: 145–153
   Web of Science ®Google Scholar
• McGuire W. P., Hoskins W. J., Brady M. F., Kucera P. R., Partridge E. E., Look K. Y., Clarke-Pearson D. L., Davidson M. Cyclophosphamide and cis-platin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 1996; 334: 1–6
   PubMed Web of Science ®Google Scholar
• Cok S. J., Acton S. J., Morrison A. R. The proximal region of the 3-untranslated region of cyclooxygenase-2 is recognized by a multimeric protein complex containing HuR, TIA-1, TIAR, and the heterogeneous nuclear ribonucleoprotein U. J Biol Chem 2003; 278: 36157–36162
   PubMed Web of Science ®Google Scholar
• Dixon D. A. Dysregulated post-transcriptional control of COX-2 gene expression in cancer. Curr Pharm Des 2004; 10: 635–646
   PubMed Web of Science ®Google Scholar
• Dixon D. A., Balch G. C., Kedersha N., Anderson P., Zimmerman G. A., Beauchamp R. D., Prescott S. M. Regulation of cyclooxygenase-2 expression by the translational silencer TIA-1. J Exp Med 2003; 198: 475–481
   PubMed Web of Science ®Google Scholar
• Dixon D. A., Tolley N. D., King P. H., Nabors L. B., McIntyre T. M., Zimmerman G. A., Prescott S. M. Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells. J Clin Investig 2001; 108: 1657–1665
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay D., Houchen C. W., Kennedy S., Dieckgraefe B. K., Anant S. Coupled mRNA stabilization and translational silencing of cyclooxygenase-2 by a novel RNA binding protein, CUGBP2. Mol Cell 2003; 11: 113–126
   PubMed Web of Science ®Google Scholar
• Muller-Decker K., Neufang G., Berger I., Neumann M., Marks F., Furstenberger G. Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis. Proc Natl Acad Sci USA 2002; 99: 12483–12488
   PubMed Web of Science ®Google Scholar
• Oshima M., Dinchuk J. E., Kargman S. L., Oshima H., Hancock B., Kwong E., Trzaskos J. M., Evans J. F., Taketo M. M. Suppression of intestinal polyposis in Apc 716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996; 87: 803–809
   PubMed Web of Science ®Google Scholar
• Brunet A., Bonni A., Zigmond M. J., Lin M. Z., Juo P., Hu L. S., Anderson M. J., Arden K. C., Blenis J., Greenberg M. E. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999; 96: 857–868
   PubMed Web of Science ®Google Scholar
• Gao L. J., Qiu W., Wang Y. W., Xu W. H., Xu J., Tong J. X. Sublytic Complement C5b-9 Complexes Induce Thrombospondin-1 Production in Rat Glomerular Mesangial cells via PI3-k/Akt: Association with Activation of latent Transforming Growth Factor-β1. Clin Exp Immu 2006; 144: 326–334
   PubMed Web of Science ®Google Scholar
• Roymans D., Slegers H. Phosphoinositide 3-kinase in tumor progression. Eur J Biochem 2001; 268: 487–498
   PubMedGoogle Scholar
• Shimamura H., Terada Y., Okado T., Tanaka H., Inoshita S., Sasaki S. The PI3-kinase-Akt pathway promotes mesangial cell survival and inhibits apoptosis in vitro via NF-κB and Bad. J Am Soc Nephrol 2003; 14: 1427–1434
   PubMed Web of Science ®Google Scholar
• Simon A. R., Vikis H. G., Stewart S., Fanburg B. L., Cochran B. H. Regulation of Stat3 by direct binding to the Rac1 GTPase. Science 2000; 290: 144–147
   PubMed Web of Science ®Google Scholar
• Stofega M. R., Argetsinger L. S., Wang H., Ullrich A., Carter-Su C. Negative regulation of growth hormone receptor/JAK2 signaling by signal regulatory protein alpha. J Biol Chem 2000; 275: 28222–28229
   PubMed Web of Science ®Google Scholar
• Jemal A., Murray T., Ward E., Samuels A., Tiwari R. C., Ghafoor A., Feuer E J., Thun M. J. Cancer Statistics, 2005. CA Cancer J Clin, 55(1)10–30
   PubMed Web of Science ®Google Scholar
• Kawamori T., Wakabayashi K. COX-2 and prostanoid receptors: good targets for chemoprevention. J Environ Pathol Toxicol Oncol 2002; 21(2)149–153
   PubMedGoogle Scholar
• Hanif R., Pittas A., Feng Y., Koutsos M. I., Qiao L., Staiano-Coico L., Shiff S. I., Rigas B. Effects of nonsteroidal anti-infl amatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem Pharmacol 1996; 52: 237–245
   PubMed Web of Science ®Google Scholar
• Yu H. P., Shi L. Y., Lu W. H., Su Y. H., Li Y. Y., Xu S. Q. Expression of cyclooxygenase-2 (COX-2) in human esophageal cancer and in vitro inhibition by a specific COX-2 inhibitor, NS-398. J Gastroenterol Hepatol 2004; 19: 638–642
   PubMed Web of Science ®Google Scholar
• Choi E. M., Kwak S. J., Kim Y. M., Ha K. S., Kim J. I., Lee S. W., Han J. A. COX-2 inhibits anoikis by activation of the PI-3K/Akt pathway in human bladder cancer cells. Exp Mol Med 2005; 37: 199–203
   PubMed Web of Science ®Google Scholar
• Liu X. H., Yao S., Kirschenbaum A., Levine A. C. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells. Cancer Res 1998; 58: 4245–4249
   PubMed Web of Science ®Google Scholar
• Hida T., Leyton J., Makheja A. N., Ben-Av P., Hla T., Martinez A., Mulshine J., Malkani S., Chung P., Moody T. W. Non-small cell lung cancer cycloxygenase activity and proliferation are inhibited by non-steroidal antiinfl ammatory drugs. Anticancer Res 1998; 18: 775–782
   PubMed Web of Science ®Google Scholar
• Kim S. H., Song S. H., Kim S. G., Chun K. S., Lim S. Y., Na H. K., Kim J. W., Surh Y. J., Bang Y. J., Song Y. S. Celecoxib induces apoptosis in cervical cancer cells independent of cyclooxygenase using NFkappaB as a possible target. J Cancer Res Clin Oncol 2004; 130: 551–560
   PubMed Web of Science ®Google Scholar
• Shimamura H., Terada Y., Okado T., Tanaka H., Inoshita S., Sasaki S. The Pi3-Kinase-Akt pathway promotes mesangial cell survival and inhibits apoptosis in vitro via NF-κB and Bad. J Am Soc Nephrol 2003; 14: 1427–1434
   PubMed Web of Science ®Google Scholar